Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 3136 for “"immunotherapy"”.

  1. Immunotherapy hyperprogression

    Καθώς διευρύνονται οι γνώσεις στους τομείς της Μοριακής Βιολογίας και της Γενετικής σχετικά με το ανθρώπινο ανοσοποιητικό σύστημα, η έρευνα για τον καρκίνο αυξάνεται ακολούθως ραγδαία. Είναι γεγονός ότι μόλις τα φυσιολογικά κύτταρα μετατραπούν σε καρκινικά, προσπαθούν να αποφύγουν το ανοσοποιητικό …

    athens Repository record for Immunotherapy hyperprogression (opens in a new tab)

  2. Sublingual Immunotherapy

    … have been developed, including sublingual immunotherapy tablets. Furthermore, no longer must a patient endure allergy shots; this can now be delivered sublingually. Although this method has been shown to have high safety and efficacy, very few clinicians actually utilize this form of …

    arizona-thes Repository record for Sublingual Immunotherapy (opens in a new tab)

  3. Immunotherapy of bladder cancer

    In this study, we evaluated the feasibility and efficacy of cytokine gene therapy in a murine orthotopic model of TCC. Orthotopic tumor was established with 1 x 105 MB49 cells in C57BL/6 mice using a modified electro-cautery technique. In situ gene transfer to bladder tumors was accomplished via …

    nus Repository record for Immunotherapy of bladder cancer (opens in a new tab) Download file for Immunotherapy of bladder cancer (opens in a new tab)

  4. Immunotherapy of metastatic disease

    zurich

  5. Immunotherapy for autoimmune diabetes

    [ACCESS RESTRICTED TO THE UNIVERSITY OF MISSOURI-COLUMBIA AT AUTHOR'S REQUEST.] Type I diabetes (TID) or insulin-dependent diabetes mellitus (IDDM) is an immunemediated disease in which the beta ([beta]) cells of the pancreatic islets of Langerhans are destroyed as a consequence of inflammatory …

    missouri Repository record for Immunotherapy for autoimmune diabetes (opens in a new tab)

  6. Immunotherapy in multiple myeloma

    … therapies for MM, and suggest that a combined immunotherapy approach using pre-stimulated T cells, MM Ag primed DC and IL-2 may produce better clinical responses in MM patients.

    glasgow Download PDF for Immunotherapy in multiple myeloma (opens in a new tab)

  7. Immunotherapy for murine glioma

    Oncolytic viral immunotherapy is a novel approach to cancer treatment. Viruses can directly kill cancer cells, provide antigens to dendritic cells to stimulate a T cell response, and make cancer cells express genes of immune-enhancing cytokines locally within the tumor microenvironment. We …

    uiuc Repository record for Immunotherapy for murine glioma (opens in a new tab)

  8. Microbubble-Assisted Ultrasound Guided Immunotherapy of Cancer: A Novel Microbubble Platform for Cancer Immunotherapy

    The recent success of immunotherapy for treatment-refractory metastatic melanoma, lung cancer, and renal cell carcinoma has provided a new hope that immunotherapy can be generalized to a broader range of cancers. However, many cancers do not respond to immunotherapy, which has limited its use to a …

    utswmed Repository record for Microbubble-Assisted Ultrasound Guided Immunotherapy of Cancer: A Novel Microbubble Platform for Cancer Immunotherapy (opens in a new tab)

  9. Chemistry meets Cancer Immunotherapy: Synthesis and Characterization of Hapten-like Compounds for Selective Immunotherapy

    Chimeric antigen receptors (CARs) are able to specifically direct T cells to tumor antigens and therapy with anti-CD19 CARs has already cured cancer patients with B-cell lymphomas who have undergone long-term therapy non-successful. Despite this impressive result, the therapy is currently only …

    wurz-thes Repository record for Chemistry meets Cancer Immunotherapy: Synthesis and Characterization of Hapten-like Compounds for Selective Immunotherapy (opens in a new tab)

  10. TARGETING PTPN22 FOR CANCER IMMUNOTHERAPY

    Immunotherapies have shown remarkable success in cancer treatment. However, diverse tumor-specific immunosuppressive mechanisms dampen response rates highlighting the need for novel immunotherapeutic targets. Protein Tyrosine Phosphatase Non-Receptor Type 22 (PTPN22) is a phosphatase specific to …

    jhu Repository record for TARGETING PTPN22 FOR CANCER IMMUNOTHERAPY (opens in a new tab) Embargoed until 2027-05-01

  11. IMMUNOTHERAPY FOR T CELL MALIGNANCIES

    Antibody and chimeric antigen receptor (CAR) T cell-mediated targeted therapies have improved survival in patients with solid and hematologic malignancies. However, adults with T cell leukemias and lymphomas, collectively called T cell cancers, still face short survival and lack effective targeted …

    jhu Repository record for IMMUNOTHERAPY FOR T CELL MALIGNANCIES (opens in a new tab) Embargoed until 2027-05-01

  12. NANOPARTICLE APPROACH TO CANCER IMMUNOTHERAPY

    … corona with the use of tumor lysate as a form of immunotherapy in combination with PDT and PTT to demonstrate tri-modal photoimmunotherapy, where both complete cancer cell kill through PDT and PTT and immune activation with the tumor lysate can be achieved in vitro. The findings from this thesis …

    nus Repository record for NANOPARTICLE APPROACH TO CANCER IMMUNOTHERAPY (opens in a new tab) Download file for NANOPARTICLE APPROACH TO CANCER IMMUNOTHERAPY (opens in a new tab)

  13. IMMUNOTHERAPY TARGETING RON IN CANCER

    Recepteur d'origine nantais (RON) receptor tyrosine kinase (RTK) and its ligand, macrophage-stimulating protein (MSP), are vital players in cell proliferation, inflammation, epithelial to mesenchymal transition during carcinogenesis, as well as migration and invasion, angiogenesis and …

    nus Repository record for IMMUNOTHERAPY TARGETING RON IN CANCER (opens in a new tab) Download file for IMMUNOTHERAPY TARGETING RON IN CANCER (opens in a new tab)

  14. Overcoming Obstacles to Glioma Immunotherapy

    … of ex vivo expanded T cells for adoptive immunotherapy that is associated with diminished proliferative potential in vivo. A focus in these experiments is the targeting of tumors with T cells that are specific for antigenic determinants derived from tumor-specific mutations. Engineered T …

    umn Repository record for Overcoming Obstacles to Glioma Immunotherapy (opens in a new tab)

  15. Novel immunotherapy for paediatric cancers

    Chimeric antigen receptors (CAR) are synthetic receptors that redirect T lymphocytes to specific tumour antigens. CART cells targeting CD19 (CAR19) have demonstrated remarkable efficacy against B cell malignancies in clinic. Currently used methods of CAR gene transfer to T cells based on viral …

    unsw Repository record for Novel immunotherapy for paediatric cancers (opens in a new tab)

Page 1 of 157